Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Integra Lifesciences Corp. — Predicate Candidate Screening

29 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

75 daysmedian FDA review time
276 days90th percentile
29clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K183581Codman Disposable PerforatorsIntegra Lifesciences Corp.2019-01-20303
K183406CereLink ICP Monitor, CereLink ICP Extension CableIntegra Lifesciences Corp.2019-01-11320
K182265CodMan Certas Plus Programmable ValveIntegra Lifesciences Corp.2018-11-20910
K181902Codman Certas Plus Electronic Tool KitIntegra Lifesciences Corp.2018-10-251010
K150682CUSA Excel+Integra Lifesciences Corp.2015-12-182760
K150428Integra (R) Jarit (R) Kerrison Rongeurs, Integra (R) RugglesIntegra Lifesciences Corp.2015-04-16560
K131184INTEGRA LICOX PTO2 MONITORIntegra Lifesciences Corp.2013-08-301275
K092227JARIT, RUGGLES, R&B REDMOND/ REDMOND, MILTEX, MEISTERHAND - Integra Lifesciences Corp.2010-02-172090
K092395OSV II LUMBAR VALVE SYSTEM AND OSV II LOW FLOW LUMBAR VALVE Integra Lifesciences Corp.2009-11-191060
K081635INTEGRA MESHED BILAYER WOUND MATRIXIntegra Lifesciences Corp.2008-12-041760
K081401MAYFIELD MR/X-RAY SKULL CLAMPIntegra Lifesciences Corp.2008-10-081420
K072113INTEGRA FLOWABLE WOUND MATRIX, MODEL FWD301Integra Lifesciences Corp.2007-10-10700
K072207DURAGEN XS DURAL REGENERATION MATRIXIntegra Lifesciences Corp.2007-08-23156
K063124INTEGRA MOZAIK BONE REGENERATION MATRIX - STRIPSIntegra Lifesciences Corp.2007-01-19981
K053244LICOX IT2 COMPLETE BRAIN TUNNELING PROBE KITIntegra Lifesciences Corp.2006-05-101701
K051440MAYFIELD INFINITY SKULL CLAMPIntegra Lifesciences Corp.2005-09-201100
K050319MAYFIELD MR/CT SKULL CLAMP, MODEL 4-0-A-1104Integra Lifesciences Corp.2005-03-31500
K050492INTEGRA BONE FIXATION SYSTEMIntegra Lifesciences Corp.2005-03-14140
K043427DURAGEN II DURAL REGENERATION MATRIXIntegra Lifesciences Corp.2005-01-12302
K041620NEURA WRAP NERVE PROTECTORIntegra Lifesciences Corp.2004-07-16301
K032693DURAGEN PLUS DURAL GRAFT MATRIXIntegra Lifesciences Corp.2003-09-30281
K030289HERMETIC PLUS EXTERNAL CSF DRAINAGE SYSTEMS, INS-8301,INS-83Integra Lifesciences Corp.2003-02-26290
K022127AVAGEN WOUND DRESSINGIntegra Lifesciences Corp.2002-09-10710
K021792BILAYER MATRIX WOUND DRESSINGIntegra Lifesciences Corp.2002-08-14751
K003229BIOPATCH ANTIMICROBIAL DRESSINGIntegra Lifesciences Corp.2001-10-263810
K011168NEUROGEN NERVE GUIDEIntegra Lifesciences Corp.2001-06-22661
K992216BIOMEND EXTEND ABSORBABLE COLLAGEN MEMBRANE, BIOMEND ABSORBAIntegra Lifesciences Corp.1999-07-26251
K982180DURAGEN DURAL GRAFT MATRIXIntegra Lifesciences Corp.1999-07-063791
K990086HELIDERM COLLAGEN WOUND DRESSINGS 0.5 GRAM AND 1.0 GRAMIntegra Lifesciences Corp.1999-03-31790

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda